TOVALT ODT Drug Patent Profile
✉ Email this page to a colleague
When do Tovalt Odt patents expire, and what generic alternatives are available?
Tovalt Odt is a drug marketed by Biovail Labs Intl and is included in one NDA.
The generic ingredient in TOVALT ODT is zolpidem tartrate. There are thirty-three drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the zolpidem tartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tovalt Odt
A generic version of TOVALT ODT was approved as zolpidem tartrate by ACME LABS on April 23rd, 2007.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for TOVALT ODT?
- What are the global sales for TOVALT ODT?
- What is Average Wholesale Price for TOVALT ODT?
Summary for TOVALT ODT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 47 |
| DailyMed Link: | TOVALT ODT at DailyMed |
US Patents and Regulatory Information for TOVALT ODT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biovail Labs Intl | TOVALT ODT | zolpidem tartrate | TABLET, ORALLY DISINTEGRATING;ORAL | 021412-001 | Apr 25, 2007 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Biovail Labs Intl | TOVALT ODT | zolpidem tartrate | TABLET, ORALLY DISINTEGRATING;ORAL | 021412-002 | Apr 25, 2007 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
